Evidence map›Paper›PMID 38322710›Full record

ArticleFrontiers in molecular biosciences2023

Aromatic amino acid metabolites alter interferon signaling and influenza pathogenesis.

Gautam Anand, Colin Clark-Dinovo, Alexandra M Perry, Victoria M Goodwin, Emma St Raymond, Sonia Sakleshpur, Ashley L Steed

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gautam AnandDepartment of Pediatrics, Washington University School of Medicine, Saint Louis, MO, United States.
Colin Clark-DinovoDepartment of Pediatrics, Washington University School of Medicine, Saint Louis, MO, United States.
Alexandra M PerryDepartment of Pediatrics, Washington University School of Medicine, Saint Louis, MO, United States.
Victoria M GoodwinDepartment of Pediatrics, Washington University School of Medicine, Saint Louis, MO, United States.
Emma St RaymondDepartment of Pediatrics, Washington University School of Medicine, Saint Louis, MO, United States.
Sonia SakleshpurDepartment of Pediatrics, Washington University School of Medicine, Saint Louis, MO, United States.
Ashley L SteedDepartment of Pediatrics, Washington University School of Medicine, Saint Louis, MO, United States.
Washington University in St. Louis · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
INTESTINAL MICROBIAL REGULATION OF ANTIVIRAL IMMUNITYK08AI135097 · NIAID · WASHINGTON UNIVERSITY · PI STEED, ASHLEY · 2018 to 2022
$878k
NIAID NIH HHS K08 AI135097NICHD NIH HHS K12 HD000850
6 · The paper itself

Abstract

The ability of gut microbial metabolites to influence the host is increasingly recognized. The microbiota extensively metabolizes the three aromatic amino acids, tryptophan, tyrosine, and phenylalanine. Previously we have found that a metabolite of tyrosine, 4-OH-phenylpropionic acid, can enhance type I interferon (IFN) signaling and protect from influenza pathogenesis in a murine model. Herein we screened 17 related aromatic amino acid metabolites for effects on IFN signaling in human lung epithelial cells and monocytes alone and in the presence of IFN-β, influenza, and LPS. While the tryptophan family metabolites reduced IFN signaling in both cell types, the tyrosine and phenylalanine metabolites had varied effects, which were cell-type dependent. Pooled treatment of all these metabolites reduced IFN signaling in both cell types and suggested a tryptophan metabolite effect dominance. Strikingly, when all the metabolites were pooled together, we found reduced influenza recovery in both cell types. RNA sequencing further validated reduced viral loads and decreased IFN signaling. Single gene silencing of significantly upregulated genes identified by RNA sequencing (

Indexed as

inflammationinfluenzainterferonmicrobial metabolitesmicrobiota

Identifiers

PMID38322710
PMCPMC10844567
OpenAlexW4391138261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.